3 Drugmakers Facing a Pivotal 2015
Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?
The Most Disappointing Clinical Failures in 2014
Three Motley Fool contributors tell us what they think were the biggest drug trial failures this year.
Exciting News: A Game-Changing Shingles Vaccine Could Be On Its Way
GlaxoSmithKline plc has reported impressive late stage trial results for its shingles vaccine.
Tax-Loss Selling: 1 Stock We'd Be Glad to Sell Right Now
If you own any of these, it might be a good time to cut your losses and move on.